PIA
CABA icon

Powell Investment Advisors’s Cabaletta Bio CABA Stock Holding History

Powell Investment Advisors’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-15,000
Closed -$30K – 142
2022
Q1 		$30K Buy
+15,000
New +$39.2K 0.02% 125

Other funds holding CABA

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Powell Investment Advisors's CABA Position: Q2 2022 in Review

Powell Investment Advisors sold out of Cabaletta Bio (CABA) in Q2 2022, closing a stake of 15,000 shares — an estimated $30K sold.

Powell Investment Advisors first reported a position in CABA in Q1 2022 and held it in 1 quarter. The position peaked at $30K in Q1 2022. 55 funds tracked by Wall St. Rank hold CABA as of Q2 2022.

  • Powell Investment Advisors reported no remaining Cabaletta Bio position as of Q2 2022 after selling out during the quarter.
  • Powell Investment Advisors sold 15,000 Cabaletta Bio shares in Q2 2022, an estimated $30K.
  • Powell Investment Advisors first reported a position in Cabaletta Bio in Q1 2022 and held it in 1 quarter.
  • Powell Investment Advisors's Cabaletta Bio position peaked at $30K in Q1 2022.
  • 55 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2022.

Based on Powell Investment Advisors's 13F filing for Q2 2022, filed 2 Aug 2022.